State Street’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $206K | Hold |
124,911
| – | – | ﹤0.01% | 3825 |
|
2025
Q1 | $166K | Hold |
124,911
| – | – | ﹤0.01% | 3869 |
|
2024
Q4 | $234K | Buy |
124,911
+68,300
| +121% | +$128K | ﹤0.01% | 3815 |
|
2024
Q3 | $43.9K | Hold |
56,611
| – | – | ﹤0.01% | 4120 |
|
2024
Q2 | $42.5K | Hold |
56,611
| – | – | ﹤0.01% | 4168 |
|
2024
Q1 | $60K | Hold |
56,611
| – | – | ﹤0.01% | 4127 |
|
2023
Q4 | $59.4K | Hold |
56,611
| – | – | ﹤0.01% | 4165 |
|
2023
Q3 | $63.4K | Hold |
56,611
| – | – | ﹤0.01% | 4227 |
|
2023
Q2 | $85.2K | Sell |
56,611
-800
| -1% | -$1.2K | ﹤0.01% | 4279 |
|
2023
Q1 | $89.6K | Hold |
57,411
| – | – | ﹤0.01% | 4351 |
|
2022
Q4 | $36.6K | Hold |
57,411
| – | – | ﹤0.01% | 4626 |
|
2022
Q3 | $76K | Hold |
57,411
| – | – | ﹤0.01% | 4554 |
|
2022
Q2 | $127K | Sell |
57,411
-361,134
| -86% | -$799K | ﹤0.01% | 4408 |
|
2022
Q1 | $2.59M | Buy |
418,545
+20,703
| +5% | +$128K | ﹤0.01% | 3471 |
|
2021
Q4 | $5.02M | Sell |
397,842
-443,178
| -53% | -$5.59M | ﹤0.01% | 3240 |
|
2021
Q3 | $77.1M | Sell |
841,020
-121,795
| -13% | -$11.2M | ﹤0.01% | 1476 |
|
2021
Q2 | $51M | Sell |
962,815
-103,065
| -10% | -$5.46M | ﹤0.01% | 1831 |
|
2021
Q1 | $38.4M | Buy |
1,065,880
+241,230
| +29% | +$8.69M | ﹤0.01% | 1933 |
|
2020
Q4 | $22.9M | Buy |
824,650
+538,320
| +188% | +$15M | ﹤0.01% | 2166 |
|
2020
Q3 | $14.3M | Buy |
286,330
+1,150
| +0.4% | +$57.5K | ﹤0.01% | 2232 |
|
2020
Q2 | $13.2M | Buy |
285,180
+91,128
| +47% | +$4.22M | ﹤0.01% | 2265 |
|
2020
Q1 | $8.85M | Buy |
194,052
+18,125
| +10% | +$827K | ﹤0.01% | 2351 |
|
2019
Q4 | $9.88M | Buy |
175,927
+125,098
| +246% | +$7.02M | ﹤0.01% | 2529 |
|
2019
Q3 | $1.27M | Buy |
50,829
+12,384
| +32% | +$309K | ﹤0.01% | 3351 |
|
2019
Q2 | $976K | Buy |
+38,445
| New | +$976K | ﹤0.01% | 3424 |
|